TrialOral oncology2012

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

Howard S Moskowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.